Study of XS411 for early-onset Parkinson's disease
Part of Brain & nervous system clinical trials.
This trial tests a new treatment called XS411 for people with early-onset Parkinson's disease (age 50 or younger at diagnosis). It is for those whose motor symptoms are not well controlled with standard medications and who may benefit from a neurosurgical procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with Parkinson's between ages 18 and 50.
- You are between 18 and 70 years old now.
- You have had Parkinson's for at least 5 years.
- Your motor symptoms are not well controlled despite stable medication.
- You are able to undergo brain surgery and anesthesia.
- You agree not to have other elective brain surgery or join other trials for 24 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug, PDR-001, to see if it can safely remove harmful proteins from the brain in people with early Parkinson's disease. It may help slow down the disease.
This trial tests a new treatment called NouvNeu001 for people with Parkinson's disease. It aims to see if it's safe, feasible, and effective in improving motor symptoms.
This trial studies whether a special type of stem cell treatment can help people with Parkinson's disease or certain atypical parkinsonism conditions. The treatment involves harvesting your own bone marrow stem cells and optimizing them in the lab before giving them back to you. It aims to see if this can slow down the disease or improve symptoms.
This trial tests a new oral medication, VG081821AC, in people with early to mid-stage Parkinson's disease. The goal is to see if it can improve movement symptoms and slow the progression of the condition, and it may offer a new treatment option for those not yet on levodopa.
This trial tests whether transplanting specially grown cells (DopaCell) into the brain can safely help people with moderate Parkinson's disease whose symptoms aren't well controlled by medication. The cells are intended to produce dopamine, the chemical that Parkinson's affects.
This trial uses special stem cells (made from skin or blood cells) to replace damaged brain cells in people with Parkinson's. The goal is to see if these cells can improve movement and reduce symptoms.
Hear when a new Parkinson Disease (PD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.